GT Biopharma Inc.

NASDAQ: GTBP
Share price (3/25/25): $2.36
Market cap (3/25/25): $5.273 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Insider Ownership

Urban Alan Louis »

Ohri Manu »

Breen Michael Martin »

Casamento Charles J »

Shrotriya Rajesh C MD »

Wendel Bruce »

Berk Gregory »

Choy Gavin »

Weldon Steven W »

Cataldo Tony »

Urbanski Raymond W. »

Cross Shawn »

Clarence-Smith Kathleen »

Bristol Capital LLC »

Saloff David »

Eaton Kenneth Haynes »

Dube Anshuman »

Hoog Thomas W »

Post Gary M »

Handelman Michael D »

Landes Bernard »

Hausman Marvin S MD »

Repine John E »

Neill Sydney Colin »

Spolar Matthew R »

Centron Michael D »

Rodell Timothy C Jr »

Guillen Steven T »

ODonnell Manus H »

Vlak Gerard J M »

Bruinsma Gosse B »

Ferris Steven H »

Davis Richard A »

Wolf Thomas M »

Rogers Ray R »

Ellis Sharon »

Webb Ted Ford »

Pryor William G »

Meridian Financial Group Llp »

≥5% Ownership

Cytovance Biologics Inc »

Bristol Investment Fund Ltd »

Armistice Capital, LLC »

Bigger Capital Fund L P »

Alpha Capital Anstalt »

Heavener James W »

Silverman Mark J »

Theorem Group, LLC »

Kasower Adam »

Horizon Pharmaceutical LLC »

Silverback Asset Management LLC »

Putnam LLC »

Bank Pictet & Cie (Europe) AG »

Alta Berkeley II LP »